For Providers
AI-Supported Prostate MRI Analysis for More Confident Clinical Decisions
Clinically Validated & Globally Certified
✔ FDA-cleared (US)
✔ CE-marked (EU)
✔ UKCA-certified (UK)
Designed to Support Clinical Decision-Making
DeepView Imaging provides fast, objective analysis ofprostate MRI scans using FDA-cleared AI, helping physicians and patients gainadditional confidence in imaging interpretation.
Independent, AI-driven second-look analysis(10–30 minutes)
Built on ProstatID® (FDA-cleared,CE-marked, UKCA-certified)
Standardized outputs aligned with PI-RADSmethodology
No disruption to your workflow or reportingsystems
Requires only non-contrast (biparametric) MRI
Variability in Prostate MRI Interpretation Is Well Documented
Despite advances in prostate MRI and PI-RADS standardization, interpretation variability remains a challenge across clinical settings.
Inter-reader agreement varies significantly, even among experienced radiologists
Subtle lesions can be missed or scored differently
Access to subspecialty expertise is inconsistent across regions
DeepView Imaging provides an additional, objective layer of analysis to help reduce uncertainty and support more confident clinical decisions.
A Complement to Your Clinical Judgment
DeepView Imaging is designed to integrate seamlessly into existing care pathways.
Patients independently upload their MRI scans
AI analysis is performed using ProstatID
A structured report and AI-annotated DICOM images are generated within minutes
Patients can share results with their physician for discussion
The platform does not provide medical advice or treatment recommendations. It delivers standardized imaging insights to support physician-led care.
Built on Clinically Validated AI
DeepView Imaging leverages ProstatID® by BotImage, one of the most advanced AI platforms for prostate MRI analysis.
Detection and localization of suspicious lesions
Cancer probability scoring
Automated PI-RADS scoring support
3D prostate segmentation and volume analysis
FDA510(k)-cleared (US) – Screening, Detection (CADe) & Diagnosis (CADx)
CE-marked (EU)
UKCA-certified (UK)
Clear, Structured, and Clinically Useful Output
Each analysis generates a detailed report designed for bothphysician review and patient understanding.
Lesion detection with location mapping
Cancer likelihood scoring
AI-assisted PI-RADS categorization
Color-overlay visualization on MRI images
Prostate volume and segmentation data
Where DeepView Imaging Adds Value
Provides a second-look review to strengthen confidence and support more informed clinical decisions.
Second-Look Confirmation: Reinforce confidencein initial reads
Discordant Findings: PSA vs MRI mismatch,borderline PI-RADS
Pre-Biopsy Decision Support
Active Surveillance monitoring
Limited access to subspecialty radiology
Better Outcomes Without Adding Work
Delivers fast, objective insights that improve clarity and support better decisions.
Clinical Confidence through objective analysis
Improved patient engagement and understanding
No workflow disruption or integration required
Fast turnaround (10–30 minutes)
No referral required
How It Works
Patient Obtains MRI
Standard non-contrast MRI (bpMRI - biparametric) at any compatible imaging center
(GE, Siemens, or Philips MRI machines)
(GE, Siemens, or Philips MRI machines)
Upload to DeepView
Patient or provider uploads DICOM images via our secure, HIPAA-compliant platform
AI Analysis
ProstatID™ processes the study, identifying and scoring suspicious lesions
Results Delivered
A detailed report and enhanced DICOM series available within 10-30 minutes
Clinical Discussion
Patient and their physician review findings; plan next steps with objective AI-supported data
The better way to launch and update your business
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Intuitive Dashboard
Our dashboard provides a clear overview. Discover how our platform can transform to your operations.
Clinical Workflow Integration
For Urologists:
Receive whole-organ visualization and 3D roadmaps for cognitive biopsy guidance
Enhance treatment planning with precise lesion localization
Support shared decision-making with patients using clear visual evidence
Improve active surveillance protocols with consistent, objective monitoring
For Primary Care Physicians:
Offer patients a non-invasive screening option before referral
Receive actionable results to guide specialist referrals
Reduce patient anxiety with faster, clearer diagnostic pathways
Support elevated PSA workups with objective AI analysis
For Radiologists & Imaging Centers*:
Results integrate seamlessly with existing PACS infrastructure
AI output appends to patient studies; no additional equipment or workflow disruption
Enhance diagnostic confidence without replacing clinical judgment
Potential CPT reimbursement for 3D reconstruction services
* Contact BotImage AI for automated integration
AI-Supported Detection
Enhance prostate MRI interpretation with AI trained on biopsy-confirmed data helps identify areas that may warrant closer evaluation.
Clinical Decision Support
Gain clearer insights into lesion location, size, and risk to support biopsy planning, treatment decisions, or active surveillance.
Improved Detection Confidence
AI-assisted analysis helps highlight suspicious regions and reduce the risk of missed clinically significant cancer.
Second Opinion Confidence
Access an additional layer of review to validate findings, reduce uncertainty, and support more informed clinical decisions.
Seamless Workflow Integration
Designed to integrate with existing radiology workflows, delivering insights quickly without disrupting your process.
Reduced Variability
Standardize interpretation across readers by supporting more consistent MRI evaluation.
Frequently Asked Questions
Does this replace the radiologist?
.svg)
.svg)
No. This is an adjunct tool that provides an additional datapoint.
Will this create confusion for patients?
Reports are designed to be clear and should be reviewed with physicians.
Is this offering medical advice?
No. It provides AI-generated analysis only and is intended to be used as another data point when determining a treatment plan.
Does it require contrast MRI?
No. Supports both bpMRI and mpMRI
Which MRI systems are compatible?
ProstatID™ is trained and validated on GE, Siemens, and Philips platforms, with additional systems in development.
Is patient data secure?
DeepView Imaging and ProstatID are fully HIPAA-compliant.
How should I incorporate this into care?
As a supplemental input similar to a second read or second opinion.
As an Imaging Service Provider, how can I incorporate ProstatID into our service?
Contact Bot Image to receive a demo, details on integrating with your PACs platform, and potential interpretation reimbursement for 3D reconstruction output. ProstatID meets the requirements to utilize CPT reimbursement code for its 3D output.
